Status:
UNKNOWN
Does Precise Delivery of Remifentanil Decrease Coughing at Emergence From Anesthesia
Lead Sponsor:
University of Vermont Medical Center
Conditions:
Cough
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The investigators want to find a way to reduce or stop patients from coughing at the end of surgery when the breathing tube is taken out. The breathing tube is removed when the participants are waking...
Eligibility Criteria
Inclusion
- Between the ages of 18 and 80
- ASA of 1-3
- Undergoing any of the following elective cases:
- thyroidectomy (partial or complete)
- parathyroidectomy
- ophthalmological surgery
- Will require endotracheal intubation.
Exclusion
- Lean Body Mass \< 20 kg,
- BMI \> 45
- Presence of pulmonary dysfunction
- Any history of anaphylaxis to remifentanil
- Requiring the use of total intravenous anesthesia.
- Per the discretion of the anesthesia provider
Key Trial Info
Start Date :
February 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03783676
Start Date
February 15 2019
End Date
June 1 2019
Last Update
December 24 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.